Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Daar

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Plos One|June 11, 2015
Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with MenSara Gianella, Davey M Smith, Eric S Daar, et al.
Journal of Virology|August 9, 2013
Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerizationEmily A Sloan, Mary F Kearney, Laurie R Gray, et al.
Journal of Clinical Pharmacology|September 26, 2018
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through AdulthoodJincheng Yang, Mina Nikanjam, Brookie M Best, et al.
AIDS and Behavior|February 4, 2015
A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIVBrent A Moore, Marc I Rosen, Yan Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224sGrace A McComsey, Douglas Kitch, Paul E Sax, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2006
Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partnersDavey M Smith, Lydia N Drumright, Simon D W Frost, et al.
Antiviral Therapy|December 25, 2012
Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV diseaseBruce R Schackman, David W Haas, Jessica E Becker, et al.
Pain Medicine (Malden, Mass.)|April 10, 2013
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathiesTaylor Harrison, Sachiko Miyahara, Anthony Lee, et al.
The Journal of Infectious Diseases|May 25, 2011
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202Grace A McComsey, Douglas Kitch, Eric S Daar, et al.
Pharmacogenetics and Genomics|January 19, 2017
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202Anurag Verma, Yuki Bradford, Shefali S Verma, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Plos One|June 11, 2015
Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with MenSara Gianella, Davey M Smith, Eric S Daar, et al.
Journal of Virology|August 9, 2013
Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerizationEmily A Sloan, Mary F Kearney, Laurie R Gray, et al.
Journal of Clinical Pharmacology|September 26, 2018
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through AdulthoodJincheng Yang, Mina Nikanjam, Brookie M Best, et al.
AIDS and Behavior|February 4, 2015
A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIVBrent A Moore, Marc I Rosen, Yan Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224sGrace A McComsey, Douglas Kitch, Paul E Sax, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2006
Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partnersDavey M Smith, Lydia N Drumright, Simon D W Frost, et al.
Antiviral Therapy|December 25, 2012
Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV diseaseBruce R Schackman, David W Haas, Jessica E Becker, et al.
Pain Medicine (Malden, Mass.)|April 10, 2013
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathiesTaylor Harrison, Sachiko Miyahara, Anthony Lee, et al.
The Journal of Infectious Diseases|May 25, 2011
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202Grace A McComsey, Douglas Kitch, Eric S Daar, et al.
Pharmacogenetics and Genomics|January 19, 2017
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202Anurag Verma, Yuki Bradford, Shefali S Verma, et al.
Pageof 23